These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 826069)

  • 21. [Chelating therapy in beta-thalassemia].
    Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
    Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Correlation between Heart, Liver and Pancreas Hemosiderosis Measured by MRI T2* among Thalassemia Major Patients from Iran.
    Azarkeivan A; Hashemieh M; Shirkavand A; Sheibani K
    Arch Iran Med; 2016 Feb; 19(2):96-100. PubMed ID: 26838079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of thalassemia in Los Angeles.
    Hyman CB; Ortega JA; Costin G; Landing B; Lazerson J; Leimbrock S; Lurie P
    Birth Defects Orig Artic Ser; 1976; 12(8):43-52. PubMed ID: 1009234
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiological findings, transfusional regimen, hepatic biopsy and splenectomy in 16 thalassemic patients in the post-pediatric age].
    Montaldo PL; Loddo M; Satta L; Multineddu R; Perpignano G; Pintus A; Lixi M; Carcassi U
    Boll Soc Ital Cardiol; 1979; 24(1):87-91. PubMed ID: 161970
    [No Abstract]   [Full Text] [Related]  

  • 25. Splenectomy for children with thalassemia.
    Al-Salem AH; Nasserulla Z
    Int Surg; 2002; 87(4):269-73. PubMed ID: 12575813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Liver iron overload and liver fibrosis in thalassemia.
    Angelucci E; Baronciani D; Lucarelli G; Giardini C; Galimberti M; Polchi P; Martinelli F; Baldassarri M; Muretto P
    Bone Marrow Transplant; 1993; 12 Suppl 1():29-31. PubMed ID: 8374556
    [No Abstract]   [Full Text] [Related]  

  • 27. Hepatitis C in patients with β-thalassemia major. A single-centre experience.
    Triantos C; Kourakli A; Kalafateli M; Giannakopoulou D; Koukias N; Thomopoulos K; Lampropoulou P; Bartzavali C; Fragopanagou H; Kagadis GC; Christofidou M; Tsamandas A; Nikolopoulou V; Karakantza M; Labropoulou-Karatza C
    Ann Hematol; 2013 Jun; 92(6):739-46. PubMed ID: 23412560
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ADAMTS13 Levels in Young Patients With β-Thalassemia Major: Relation to Hepatitis C Virus Infection, Liver Cirrhosis, and Iron Overload.
    Hamed AA; Darwish YW; El-Sayed MH
    Clin Appl Thromb Hemost; 2015 Sep; 21(6):527-32. PubMed ID: 25430937
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Partial splenectomy in the treatment of thalassaemia major.
    Kheradpir MH; Alebouyeh M
    Z Kinderchir; 1985 Aug; 40(4):195-8. PubMed ID: 4060888
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up.
    Casale M; Cinque P; Ricchi P; Costantini S; Spasiano A; Prossomariti L; Minelli S; Frega V; Filosa A
    Eur J Haematol; 2013 Jul; 91(1):69-73. PubMed ID: 23581970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT in B-thalassemia: iron deposition in the liver, spleen, and lymph nodes.
    Mitnick JS; Bosniak MA; Megibow AJ; Karpatkin M; Feiner HD; Kutin N; Van Natta F; Piomelli S
    AJR Am J Roentgenol; 1981 Jun; 136(6):1191-4. PubMed ID: 6786034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of iron overload and hepatitis C virus positivity in determining progression of liver fibrosis in thalassemia following bone marrow transplantation.
    Angelucci E; Muretto P; Nicolucci A; Baronciani D; Erer B; Gaziev J; Ripalti M; Sodani P; Tomassoni S; Visani G; Lucarelli G
    Blood; 2002 Jul; 100(1):17-21. PubMed ID: 12070002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beta-thalassaemia--the Johannesburg experience.
    Poole JE; Cohn RJ; Roode H; Spector I
    S Afr Med J; 1989 Apr; 75(8):367-70. PubMed ID: 2652340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of partial splenectomy in children with thalassemia.
    al-Salem AH; al-Dabbous I; Bhamidibati P
    Eur J Pediatr Surg; 1998 Dec; 8(6):334-8. PubMed ID: 9926300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of deferiprone on liver iron overload and fibrosis in hepatitis-C-virus-infected thalassemia.
    Chen AC; Peng CT; Wu SF; Wu KH; Chiang IP; Tsai CH
    Hemoglobin; 2006; 30(2):209-14. PubMed ID: 16798645
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined long-term treatment of hemosiderosis with desferioxamine and DTPA in homozygous beta-thalassemia.
    Constantoulakis M; Economidou J; Karagiorga M; Katsantoni A; Gyftaki E
    Ann N Y Acad Sci; 1974; 232(0):193-200. PubMed ID: 4528481
    [No Abstract]   [Full Text] [Related]  

  • 37. Liver fibrosis and iron levels during long-term deferiprone treatment of thalassemia major patients.
    Wu SF; Peng CT; Wu KH; Tsai CH
    Hemoglobin; 2006; 30(2):215-8. PubMed ID: 16798646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum ferritin levels in thalassemias and the effect of splenectomy.
    Pootrakul P; Vongsmasa V; La-ongpanich P; Wasi P
    Acta Haematol; 1981; 66(4):244-50. PubMed ID: 6800190
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Iron concentration in teeth of patients with and without beta-thalassaemia major.
    Garfunkel A; Kantzuker M; Gedalia I; Chevion M
    Arch Oral Biol; 1979; 24(10-11):829-31. PubMed ID: 295607
    [No Abstract]   [Full Text] [Related]  

  • 40. Heme oxygenase/carbon monoxide pathway inhibition plays a role in ameliorating fibrosis following splenectomy.
    Wang QM; Duan ZJ; Du JL; Guo SB; Sun XY; Liu Z
    Int J Mol Med; 2013 May; 31(5):1186-94. PubMed ID: 23525258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.